← All trials
NCT06716853
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 22, 2024
- Primary completion
- Sep 30, 2026
- Completion date
- Sep 30, 2026
- First posted
- Dec 4, 2024
- Last posted
- Dec 4, 2024
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Genenta Science S.R.L.Lead sponsor
- Vita-Salute University of Milano. ItalyCollaborator
- Alira HealthCollaborator
- Arithmos srlCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.